Figure 2 Comparison of pregnancy outcomes between true NC-FET and modified NC-FET. Odds ratio (OR) adjusted for clinical pregnancy (OR 0.90, 95% CI 0.73–1.12)

Slides:

Advertisements

Similar presentations

From: An open day in the metric space

Advertisements

Fig. 3. Plot of overall survival by adjuvant therapy for patient subgroups. (A) Patients with M0 disease (n = 411). (B) Patients receiving 36 Gy craniospinal.

Fig. 1 Flow chart of the COBRA-light trial and its extension study

From: Global Banking: Recent Developments and Insights from Research*

Figure 2. Quality of life (QOL) scores for functional scale items

Fig. 1 Graphical representation

Figure 3. Day 2 cell symmetry

Figure 2. CONSORT flow diagram.

Figure 1 Cumulative chance of pregnancy according to age at initiation of pregnancy seeking. The curves were drawn based on the following assumptions:

Figure 1. Mean recalled time (days) since the start of the last quit attempt by use of stop-smoking medications (SSM) and Heaviness of Smoking Index (HSI)

Source:Ellerman, Convery, and de Perthuis (2010). Figure 6. 2, p

pSS: primary SS; Scl: scleroderma.

Figure 1. Selection of papers.

Fig. 1 Flow chart of study selection

Figure 1. Conceptual model of well-being related to involvement in theatre. From: Theatre Involvement and Well-Being, Age Differences, and Lessons From.

Figure 1. (A) Forest plot of common odds ratios (adjusted for ECOG PS) for best overall response by a priori subgroups in patients with KRAS wild-type.

Figure 1 Individual Lifted from Group Photograph

Figure 1. Orthodontic set-up and location of LLLT or placebo-laser

Fig. 1 Flow of ascertainment of cases with incident childhood IgA vasculitis reported by four sources From: Incidence of IgA vasculitis in children estimated.

Figure 2. Illustration of minimum cross-sectional area (a) and measurements for oropharynx and soft palate in sagittal plane (b, c). From: Airway volume.

From: Unmasking Masks in Makkah: Preventing Influenza at Hajj

Figure 2. (A) Sézary syndrome patient before treatment

Fig 1 Respiratory support escalation strategies for study patients

Figure 1 Flow chart showing the selection of publications identified in the literature search. From: GnRH antagonist versus long agonist protocols in IVF:

From: Where do we go from here

From: A European Disease

Example 14. Schubert, Quartet in G Major, D

Figure 1. Nonadherence to guidelines for prescribing antiplatelet and anticoagulant therapy in 144 patients with atrial fibrillation who attend a Spanish.

Fig. 1 Selection of patients

Figure 1 Study flowchart.

Fig. 1 Flow diagram of patient selection and study design.

Figure 1 Flow chart of search and selection strategy for studies in a systematic review of endometrial thickness during IUI with ovarian stimulation. *

Figure 1. Orthodontic set-up and location of LLLT or placebo-laser

Figure 1 Flow of data processing

From: Estimating the Location of World Wheat Price Discovery

Figure 1: Time points at which sperm samples were analysed for aneuploidy frequencies in controls and cancer patients From: Sperm aneuploidy frequencies.

Figure 1: Logistic regression showing association of prescribing provider and patient panel characteristics with occurrence of a hospitalization or ED.

Figure 3. Visualisation of ESMO-MCB scores for curative and non-curative setting. A & B and 5 and 4 represent the grades with substantial improvement.

Figure 1. Dosage and administration route of drugs used in the BMD study. Each cycle was proposed every 28 days (‘base’ schedule) or 35 days (‘weekly’

Figure 1. Percentage of trainees is represented on the y-axis for each competency/knowledge item represented in the x-axis. Only Poor/Fair (P/F) ratings.

Figure 1 Study flow chart

Figure 1 Flowchart for the study population.

Figure 1 PRISMA flow diagram illustrating the process of selection of studies for inclusion in the systematic review. From: How effective are weight-loss.

Figure 1. Impact ratings for prospective memory lapses for younger (~age 30), middle-age (~age 50), and older (~age 65) adults. From: Daily Memory Lapses.

Figure 1. Scattergram of serum CA-125 levels in 775 consecutive patients who had been diagnosed with gynecologic disease by laparotomy or laparoscopy.

Figure 6. RRs for clinical cure rates stratified by different diseases

Figure 1. Progression-free survival and overall survival for FL/DLBCL patients. From: Clinicobiological features and prognostic impact of diffuse large.

Figure 1. Patterns of HER2–PET/CT confronted with FDG–PET/CT, Maximum intensity projection. Lesion uptake was considered pertinent when visually higher.

Figure 1. HR (95% CI) of death from dementia associated with weight or BMI in middle age and in old age. From: Adiposity in middle and old age and risk.

Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Comparison of MITRA-FR and COAPT trial outcomes

Take home figure The protective role of CNP/NPR-B/NPRC.

Fig. 1 Flow chart of included patients for analyses

Programming the endometrium for deferred transfer of cryopreserved embryos: hormone replacement versus modified natural cycles Eva R. Groenewoud, M.D.,

Figure 1 Cumulative late adjusted survival in cardiac resynchronization therapy defibrillator and pacemaker patients. ... Figure 1 Cumulative late adjusted.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1. Percentage of Pacific and European children completing all components of B4SC in 2013 and 2015 Figure 1. Percentage of Pacific and European.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Fig. 1 Kaplan-Meier plot presenting no difference in progression to RA in patients with clinically suspect ... Fig. 1 Kaplan-Meier plot presenting no difference.

Figure 1. Oncoprint of selected pathogenic alterations detected in ctDNA. Unless provided in the caption above, the following copyright applies to the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Grant agencies and charitable foundations supporting Plan S.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Figure 1 Mechanisms of mitral regurgitation.

Figure 1: Trade shares of South Korea's major trading partners (% of South Korea's total trade in goods) Figure 1: Trade shares of South Korea's major.

Figure 1 ABCDE of primary prevention.2

Figure 1. Forest plot of lung cancer mortality in LDCT trials.

Figure 1. Overall response rates in wild-type versus RAS and RAS/BRAF mutations detected by nanofluidic digital PCR ... Figure 1. Overall response rates.

Presentation transcript:

Figure 2 Comparison of pregnancy outcomes between true NC-FET and modified NC-FET. Odds ratio (OR) adjusted for clinical pregnancy (OR 0.90, 95% CI 0.73–1.12) and for live birth (OR 0.82 95% CI 0.63–1.08). NC, natural cycle; FET, frozen-thawed embryo transfer. From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2):255-261. doi:10.1093/humupd/dmw046 Hum Reprod Update | © The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Figure 3 Comparison of pregnancy outcomes between true NC-FET and modified NC-FET with a subgroup analyses for the use of luteal phase support. OR adjusted for clinical pregnancy in patients not receiving luteal phase support (OR 1.14, 95% CI 0.73–1.77) and patients receiving luteal phase support (OR 0.79, 95% CI 0.60–1.03). From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2):255-261. doi:10.1093/humupd/dmw046 Hum Reprod Update | © The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Figure 4 Comparison of pregnancy outcomes between NC-FET and artificial cycle FET (AC-FET). OR adjusted for clinical pregnancy (OR 1.18, 95% CI 0.94–1.48). From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2):255-261. doi:10.1093/humupd/dmw046 Hum Reprod Update | © The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Figure 6 Comparison of pregnancy outcomes between NC-FET and AC-FET with a subgroup analyses for the use of luteal phase support. OR adjusted for clinical pregnancy in patients receiving luteal phase support (OR 1.11, 95% CI 0.88–1.40). From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2):255-261. doi:10.1093/humupd/dmw046 Hum Reprod Update | © The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Figure 7 Comparison of pregnancy outcomes between NC-FET and AC-FET with GnRH agonist. OR adjusted for clinical pregnancy (OR 0.80, 95% CI 0.66–0.97). From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2):255-261. doi:10.1093/humupd/dmw046 Hum Reprod Update | © The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com

Figure 8 Comparison of pregnancy outcomes between AC-FET and AC-FET with GnRH agonist. OR adjusted for clinical pregnancy (OR 0.79, 95% CI 0.43–1.43). From: What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis Hum Reprod Update. 2017;23(2):255-261. doi:10.1093/humupd/dmw046 Hum Reprod Update | © The Author 2017. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com